Preoperative Serum Thyroglobulin Levels Predict Radioiodine Therapy Outcome in Papillary Thyroid Microcarcinoma Patients
Hormone and Metabolic Research · 01.07.2024 · 56 (07) · 498-503
DOI: 10.1055/a-2291-0340 ↗Kurz gefasst
Fachartikel in der Zeitschrift Hormone and Metabolic Research, erschienen am 01.07.2024. Verfasst von Xian Cheng und 8 weiteren Autor:innen. Beteiligte Einrichtung: NHC Key Laboratory of Nuclear Medicine, Jiangsu Institute of Nuclear Medicine, Wuxi. Hauptthemen laut MEDLINE: Thyroid Neoplasms, Iodine Radioisotopes, Thyroglobulin, Carcinoma, Papillary. Die Arbeit nennt 25 Literaturangaben. Gefördert von: Science and Research Foundation of Wuxi Science & Technology Bureau, Wuxi Health Commission, Science and Research Foundation of the Health Bureau of Jiangsu Province.
Abstract (Originalsprache)
Our previous study showed that elevated preoperative thyroglobulin (pre-Tg) level predicted the risk of developing radioiodine refractory in PTC patients. In the present study, we aimed to evaluate the prognostic value of pre-Tg in papillary thyroid microcarcinoma (PTMC). After a specific inclusion and exclusion criteria were applied, a total of 788 PTMCs were enrolled from Jiangyuan Hospital affiliated to Jiangsu Institute of Nuclear Medicine between Jan 2015 and Dec 2019. Among them, 107 PTMCs were treated with radioiodine therapy (RAIT) and the response to therapy was grouped as excellent response (ER), and non-excellent response (NER: indeterminate response, IDR and biochemical incomplete response, BIR). Multivariable logistic regression was used to identify predictors for the response of RAIT in PTMCs. Higher pre-Tg levels were detected in PTMCs with RAIT as compared with PTMCs without RAIT (p=0.0018). Higher levels of pre-Tg were also found in patients with repeated RAIT as compared with patients with single RAIT (p
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- NHC Key Laboratory of Nuclear Medicine, Jiangsu Institute of Nuclear Medicine, Wuxi.
Förderung
- Science and Research Foundation of Wuxi Science & Technology Bureau
- Wuxi Health Commission
- Science and Research Foundation of the Health Bureau of Jiangsu Province
- National Natural Science Foundation of China
Zitieren
APA
Cheng, X., Fan, Y., Ye, W., Xu, S., Wu, J., Gao, W., Bao, J., Yu, H., & Zhang, L. (2024). Preoperative Serum Thyroglobulin Levels Predict Radioiodine Therapy Outcome in Papillary Thyroid Microcarcinoma Patients. Hormone and Metabolic Research, 56(07), 498-503. https://doi.org/10.1055/a-2291-0340
Vancouver
Cheng X, Fan Y, Ye W, Xu S, Wu J, Gao W, et al. Preoperative Serum Thyroglobulin Levels Predict Radioiodine Therapy Outcome in Papillary Thyroid Microcarcinoma Patients. Hormone and Metabolic Research. 2024;56(07):498-503. doi:10.1055/a-2291-0340
BibTeX
@article{Cheng2024,
author = {Cheng, Xian and Fan, Yijun and Ye, Wanzhong and Xu, Shichen and Wu, Jing and Gao, Wenjing and Bao, Jiandong and Yu, Huixin and Zhang, Li},
title = {Preoperative Serum Thyroglobulin Levels Predict Radioiodine Therapy Outcome in Papillary Thyroid Microcarcinoma Patients},
journal = {Hormone and Metabolic Research},
year = {2024},
volume = {56},
number = {07},
pages = {498--503},
doi = {10.1055/a-2291-0340}
}
EUVIMED